A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

Condition:   HIVInterventions:   Drug: Nur-Isterate;   Device: Nuvaring;   Drug: TriphasilSponsor:   Desmond Tutu HIV CentreNot yet recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: NuvaRing | Research | Study